DISCUSSION OF THE REPORT OF MR. STEFANIMr. Potor SCHRAMKE · 1969

DISCUSSION OF THE REPORT OF MR. STEFANIMr. Norman HASELDINE · 1969

DISCUSSION OF THE REPORT OF MR. STEFANIMr. Raymond ZINS · 1969

DISCUSSION OF THE REPORT OF MR. STEFANIProfessor Mario LOMBARDI · 1969

DISCUSSION OF THE REPORT OF MR. STEFANIMr. Gilles DESROCHERS · 1969

DISCUSSION OF THE REPORT OF MR. STEFANIMr. Jacques CHEVRIER · 1969

DISCUSSION OF THE REPORT OF MR. STEFANIProfessor Gorhrd WEISSER · 1969

The challenges of individualized care for older patients with localized breast cancerMrózek, Ewa; Povoski, Stephen P; Shapiro, Charles L · Expert Review of Anticancer Therapy · 2013

Phase II Trial of Exemestane in Combination With Fulvestrant in Postmenopausal Women With Advanced, Hormone-Responsive Breast CancerEwa Mrózek; Rachel Layman; Bhuvaneswari Ramaswamy; Larry Schaaf; Xiaobai Li; Susan Ottman; Charles L. Shapiro · 2012

Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast CancerMrózek, Ewa; Layman, Rachel; Ramaswamy, Bhuvaneswari; Lustberg, Maryam; Vecchione, Andrea; Knopp, Michael V.; Shapiro, Charles L. · Clinical Breast Cancer · 2014

[American Thoracic Society American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California - ()] B92. NEW TREATMENT APPROACHES FOR ASTHMA AND ALLERGY - Randomized, Double-Blind, Placebo Controlled First in Human Study of Inhaled AIR645, an IL-4Rα Oligonucleotide, in Healthy Volunteers.Hodges, MR; Castelloe, E; Chen, A; Geary, RS; Karras, JG; Shapiro, D; Yeung, B; Yu, R; Gregory, SA · 2009